Cellular functions of 14-3-3ζ in apoptosis and cell adhesion emphasize its oncogenic character

Oncogene

Volumn 27, Issue 9, 2008, Pages 1315-1319

  Niemantsverdriet, M ^a,b   Wagner, K ^a   Visser, M ^a   Backendorf, C ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

14 3 3 siRNA; c Jun N terminal kinase; E cadherin; Oncomine; p38 MAPK; UV irradiation

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN 14 3 3; PROTEIN 14 3 3 ZETA; STRATIFIN; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CARCINOGENIC ACTIVITY; CELL ADHESION; CELL FUNCTION; DOWN REGULATION; HUMAN; HUMAN CELL; MULTIGENE FAMILY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

14-3-3 PROTEINS; APOPTOSIS; CELL ADHESION; CELL LINE, TUMOR; HUMANS; ISOENZYMES; ONCOGENE PROTEINS; ONCOGENES; ULTRAVIOLET RAYS;

MAMMALIA;

EID: 39749094444     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210742     Document Type: Article

References (31)

1. Arora S, Matta A, Shukla NK, Deo SV, Ralhan R. (2005). Identification of differentially expressed genes in oral squamous cell carcinoma. Mol Carcinog 42: 97-108.
2. Balda MS, Matter K. (2003). Epithelial cell adhesion and the regulation of gene expression. Trends Cell Biol 13: 310-318.
3. Beavon IR. (2000). The E-cadherin-catenin complex in tumour metastasis: structure, function and regulation. Eur J Cancer 36: 1607-1620.
4. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE. (1988). Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106: 761-771.
5. Brummelkamp TR, Bernards R, Agami R. (2002). A system for stable expression of short interfering RNAs in mammalian cells. Science 296: 550-553.
6. Buckley PG, Mantripragada KK, Benetkiewicz M, Tapia-Paez I, Diaz De Stahl T, Rosenquist M et al. (2002). A full-coverage, high-resolution human chromosome 22 genomic microarray for clinical and research applications. Hum Mol Genet 11: 3221-3229.
7. Burnworth B, Popp S, Stark HJ, Steinkraus V, Brocker EB, Hartschuh W et al. (2006). Gain of 11q/cyclin D1 overexpression is an essential early step in skin cancer development and causes abnormal tissue organization and differentiation. Oncogene 25: 4399-4412.
8. Clairotte A, Lascombe I, Fauconnet S, Mauny F, Felix S, Algros MP et al. (2006). Expression of E-cadherin and alpha-, beta-, gamma-catenins in patients with bladder cancer: identification of gamma-catenin as a new prognostic marker of neoplastic progression in T1 superficial urothelial tumors. Am J Clin Pathol 125: 119-126.
9. Dent P, Yacoub A, Fisher PB, Hagan MP, Grant S. (2003). MAPK pathways in radiation responses. Oncogene 22: 5885-5896.
10. Ghadimi BM, Grade M, Liersch T, Langer C, Siemer A, Fuzesi L et al. (2003). Gain of chromosome 8q23-24 is a predictive marker for lymph node positivity in colorectal cancer. Clin Cancer Res 9: 1808-1814.
11. Hanahan D, Weinberg RA. (2000). The hallmarks of cancer. Cell 100: 57-70.
12. Hekman M, Albert S, Galmiche A, Rennefahrt UE, Fueller J, Fischer A et al. (2006). Reversible membrane interaction of BAD requires two C-terminal lipid binding domains in conjunction with 14-3-3 protein binding. J Biol Chem 281: 17321-17336.
13. Hermeking H. (2003). The 14-3-3 cancer connection. Nat Rev Cancer 3: 931-943.
14. Hermeking H, Lengauer C, Polyak K, He TC, Zhang L, Thiagalingam S et al. (1997). 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol Cell 1: 3-11.
15. Jang JS, Cho HY, Lee YJ, Ha WS, Kim HW. (2004). The differential proteome profile of stomach cancer: identification of the biomarker candidates. Oncol Res 14: 491-499.
16. Jin Y, Dai MS, Lu SZ, Xu Y, Luo Z, Zhao Y et al. (2006). 14-3-3gamma binds to MDMX that is phosphorylated by UV-activated Chk1, resulting in p53 activation. EMBO J 25: 1207-1218.
17. Kim BJ, Ryu SW, Song BJ. (2006). JNK- and p38 kinase-mediated phosphorylation of Bax leads to its activation and mitochondrial translocation and to apoptosis of human hepatoma HepG2 cells. J Biol Chem 281: 21256-21265.
18. Niemantsverdriet M, Jongmans W, Backendorf C. (2005). Radiation response and cell cycle regulation of p53 rescued malignant keratinocytes. Exp Cell Res 310: 237-247.
19. Porter GW, Khuri FR, Fu H. (2006). Dynamic 14-3-3/client protein interactions integrate survival and apoptotic pathways. Semin Cancer Biol 16: 193-202.
20. Rhodes DR, Chinnaiyan AM. (2005). Integrative analysis of the cancer transcriptome. Nat Genet 37(Suppl): S31-S37.
21. Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D et al. (2004). ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 6: 1-6.
22. Sugiyama A, Miyagi Y, Komiya Y, Kurabe N, Kitanaka C, Kato N et al. (2003). Forced expression of antisense 14-3-3beta RNA suppresses tumor cell growth in vitro and in vivo. Carcinogenesis 24: 1549-1559.
23. Tada K, Oka M, Tangoku A, Hayashi H, Oga A, Sasaki K. (2000). Gains of 8q23-qter and 20q and loss of 11q22-qter in esophageal squamous cell carcinoma associated with lymph node metastasis. Cancer 88: 268-273.
24. Takeuchi T, Liang SB, Ohtsuki Y. (2002). Downregulation of expression of a novel cadherin molecule, T-cadherin, in basal cell carcinoma of the skin. Mol Carcinog 35: 173-179.
25. Takihara Y, Matsuda Y, Hara J. (2000). Role of the beta isoform of 14-3-3 proteins in cellular proliferation and oncogenic transformation. Carcinogenesis 21: 2073-2077.
26. Tzivion G, Gupta VS, Kaplun L, Balan V. (2006). 14-3-3 proteins as potential oncogenes. Semin Cancer Biol 16: 203-213.
27. Ueda G, Sunakawa H, Nakamori K, Shinya T, Tsuhako W, Tamura Y et al. (2006). Aberrant expression of beta- and gamma-catenin is an independent prognostic marker in oral squamous cell carcinoma. Int J Oral Maxillofac Surg 35: 356-361.
28. van Hemert MJ, Steensma HY, van Heusden GP. (2001). 14-3-3 proteins: key regulators of cell division, signalling and apoptosis. BioEssays 23: 936-946.
29. Wang B, Liu K, Lin FT, Lin WC. (2004). A role for 14-3-3 tau in E2F1 stabilization and DNA damage-induced apoptosis. J Biol Chem 279: 54140-54152.
30. Wanzel M, Kleine-Kohlbrecher D, Herold S, Hock A, Berns K, Park J et al. (2005). Akt and 14-3-3eta regulate Miz1 to control cell-cycle arrest after DNA damage. Nat Cell Biol 7: 30-41.
31. Zang L, Palmer Toy D, Hancock WS, Sgroi DC, Karger BL. (2004). Proteomic analysis of ductal carcinoma of the breast using laser capture microdissection, LC-MS, and 16O/18O isotopic labeling. J Proteome Res 3: 604-612.